- Headquarters
- Beijing, China · East Asia
- Value chain
- Medicines & vaccines(Products)
- What that means
- Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
- Founded
- 1998
- Ownership
- State-owned
- Website
- sinopharm.com
- Relevance
- Moderate at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures
Beijing, ChinaIn 2 capabilities
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Manufacture · listed #16 of 50
State-owned group whose CNBG unit makes the BBIBP-CorV inactivated COVID-19 vaccine (WHO-listed) and most of China's national immunisation programme vaccines.
Relevance: Large Chinese vaccine group, mainly domestic and Global South
- BiomanufacturingModerate
Biotechnology & Health Technologies · Manufacture · listed #25 of 50
State group whose CNBG subsidiary is China's largest vaccine and blood-products manufacturer and produced billions of COVID-19 vaccine doses.
Relevance: China’s largest vaccine maker, mainly domestic